Pd38-01 feasibility, safety and efficacy results of the sufu foundation open label clinical trial of ultrasound confirmed transvaginal botulinum toxin a (bta) for refractory overactive bladder (oab)
Journal of Urology（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要